Total Payments
$207,060
2024 Payments
$64,409
Companies
69
Transactions
843
Medicare Patients
31,238
Medicare Billing
$2.3M
Payment Breakdown by Category
Other$138,709 (67.0%)
Consulting$33,691 (16.3%)
Food & Beverage$24,463 (11.8%)
Travel$9,832 (4.7%)
Education$364.95 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $138,709 | 70 | 67.0% |
| Consulting Fee | $33,691 | 19 | 16.3% |
| Food and Beverage | $24,463 | 693 | 11.8% |
| Travel and Lodging | $9,832 | 37 | 4.7% |
| Education | $364.95 | 24 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $76,088 | 127 | $0 (2024) |
| Astellas Pharma US Inc | $55,250 | 145 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $37,135 | 101 | $0 (2024) |
| PFIZER INC. | $9,206 | 43 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $6,077 | 49 | $0 (2024) |
| Myovant Sciences Inc. | $3,980 | 7 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $3,922 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,628 | 6 | $0 (2024) |
| Astellas Pharma Global Development | $1,440 | 1 | $0 (2023) |
| Valeant Pharmaceuticals North America LLC | $1,029 | 11 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $64,409 | 143 | Janssen Biotech, Inc. ($30,604) |
| 2023 | $21,717 | 98 | Astellas Pharma US Inc ($7,670) |
| 2022 | $30,815 | 126 | Bayer HealthCare Pharmaceuticals Inc. ($10,642) |
| 2021 | $14,463 | 62 | Myovant Sciences Inc. ($3,916) |
| 2020 | $22,128 | 33 | Janssen Biotech, Inc. ($11,626) |
| 2019 | $38,962 | 125 | Janssen Biotech, Inc. ($18,481) |
| 2018 | $11,097 | 142 | Astellas Pharma US Inc ($6,285) |
| 2017 | $3,470 | 114 | Valeant Pharmaceuticals North America LLC ($1,029) |
All Payment Transactions
843 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $36.42 | General |
| Category: Oncology | ||||||
| 12/17/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $118.71 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,525.00 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $29.38 | General |
| Category: UROLOGY | ||||||
| 12/10/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/03/2024 | Cycle Pharmaceuticals Inc | Tiopronin (Drug) | Food and Beverage | In-kind items and services | $29.16 | General |
| Category: UROLOGY | ||||||
| 11/26/2024 | COLOPLAST CORP | Luja Coude (Device) | Food and Beverage | In-kind items and services | $26.98 | General |
| Category: Continence Care | ||||||
| 11/20/2024 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | Cash or cash equivalent | $22.37 | General |
| Category: ONCOLOGY | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $16.78 | General |
| Category: Prostate cancer | ||||||
| 11/07/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $550.00 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: Oncology | ||||||
| 10/31/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/25/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,575.00 | General |
| Category: Oncology | ||||||
| 10/25/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $148.94 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $140.91 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $30.92 | General |
| Category: Oncology | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $149.21 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Oncology | ||||||
| 10/15/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $20.60 | General |
| Category: Prostate cancer | ||||||
| 10/10/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 7,625 | 14,134 | $2.4M | $572,909 |
| 2022 | 35 | 7,496 | 57,714 | $2.2M | $502,831 |
| 2021 | 41 | 8,294 | 91,657 | $2.6M | $655,158 |
| 2020 | 41 | 7,823 | 68,179 | $2.4M | $580,151 |
Total Patients
31,238
Total Services
231,684
Medicare Billing
$2.3M
Procedure Codes
152
All Medicare Procedures & Services
152 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,107 | 2,133 | $940,898 | $233,396 | 24.8% |
| J1952 | Leuprolide injectable, camcevi, 1 mg | Office | 2023 | 20 | 1,134 | $325,367 | $75,858 | 23.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 158 | 201 | $193,215 | $47,130 | 24.4% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 483 | 604 | $126,427 | $32,892 | 26.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 1,228 | 2,278 | $107,518 | $22,935 | 21.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 271 | 335 | $104,857 | $22,553 | 21.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 157 | 157 | $90,869 | $22,402 | 24.7% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 666 | 977 | $53,901 | $17,606 | 32.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 784 | 1,320 | $11,880 | $11,022 | 92.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 1,248 | 2,558 | $26,706 | $8,701 | 32.6% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 24 | 24 | $31,326 | $8,527 | 27.2% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 13 | 51 | $38,645 | $6,537 | 16.9% |
| 51703 | Complicated insertion of bladder tube | Office | 2023 | 19 | 46 | $24,626 | $6,114 | 24.8% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 44 | 47 | $23,287 | $5,874 | 25.2% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 342 | 438 | $66,499 | $5,208 | 7.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 32 | 32 | $19,735 | $4,906 | 24.9% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 24 | 24 | $16,587 | $4,547 | 27.4% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 13 | 52 | $19,377 | $4,468 | 23.1% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 311 | 498 | $12,057 | $3,939 | 32.7% |
| 55899 | Other procedure on male genital system | Office | 2023 | 14 | 14 | $18,273 | $3,757 | 20.6% |
| 76870 | Ultrasound scan of scrotum | Office | 2023 | 38 | 38 | $13,257 | $3,661 | 27.6% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 12 | 13 | $12,554 | $2,984 | 23.8% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 13 | 52 | $11,438 | $2,868 | 25.1% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2023 | 114 | 309 | $8,019 | $2,619 | 32.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 30 | 32 | $10,671 | $2,316 | 21.7% |
About Dr. Matthew Mene, DO
Dr. Matthew Mene, DO is a Urology healthcare provider based in Seaford, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184687097.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Mene, DO has received a total of $207,060 in payments from pharmaceutical and medical device companies, with $64,409 received in 2024. These payments were reported across 843 transactions from 69 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($138,709).
As a Medicare-enrolled provider, Mene has provided services to 31,238 Medicare beneficiaries, totaling 231,684 services with total Medicare billing of $2.3M. Data is available for 4 years (2020–2023), covering 152 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Seaford, NY
- Active Since 04/11/2006
- Last Updated 04/02/2011
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1184687097
Products in Payments
- ERLEADA (Drug) $58,848
- Nubeqa (Drug) $32,272
- Xtandi (Drug) $31,185
- Erleada (Drug) $20,828
- XTANDI (Drug) $20,534
- MYRBETRIQ (Drug) $12,389
- PROVENGE (Drug) $7,106
- Xofigo (Drug) $4,862
- ORGOVYX (Drug) $2,728
- LYNPARZA (Drug) $2,628
- JELMYTO (Drug) $733.21
- UroLift (Device) $563.56
- Trelstar (Drug) $438.29
- Lupron (Drug) $421.98
- ELIGARD (Drug) $401.49
- Urolift - UL400 (Device) $392.90
- Natesto (Drug) $383.91
- ZYTIGA (Drug) $367.03
- GEMTESA (Drug) $359.05
- XIAFLEX (Biological) $348.49
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Seaford
Evan Eisenberg, Md, MD
Urology — Payments: $8,975
Urology $8,975
Elizabeth Kornfield Chadwell, Md, MD
Urology — Payments: $4,296
Urology $4,296
David Cohen, M.d, M.D
Urology — Payments: $2,815
Urology $2,815
Robert Mashioff, Md, MD
Urology — Payments: $142.64
Urology $142.64
Dr. Jose Barriocanal, M.d, M.D
Urology — Payments: $82.40
Urology $82.40